Share this article
Share this article
ResearchAndMarkets.com s offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the global hematology drugs market as it emerges from the COVID-19 shut down.
The global hematology drugs market is expected to grow from $78.83 billion in 2020 to $82.57 billion in 2021 at a compound annual growth rate (CAGR) of 4.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $119.92 billion in 2025 at a CAGR of 10%.
Global Wafer Handling Robots Market By Type, By Application, By Segmentation, By Region, and By Country
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients with Relapsed/Refractory B-Cell Lymphoma
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Hospital Acquired Infections Therapeutic Market Size Worth $12.5 Billion By 2027: Grand View Research, Inc.
to reach USD 12.5 billion by
2027, according to a new report by Grand View Research, Inc. The market is expected
to expand at a CAGR of 2.4% from 2020 to
2027. The high prevalence of HAIs, rise in approval and launch of new drugs, and growing hospitalization due to the rise in prevalence of chronic diseases are driving the market.
Key suggestions from the report:
Antibacterial drugs dominated the drug class segment in 2019, owing to the high adoption of antibiotics as the first line of treatment for hospital-acquired infections (HAIs)
The surgical site infections (SSIs) segment held the largest market share in 2019 due to the rising number of surgical procedures and subsequent rising cases of SSIs